메뉴 건너뛰기




Volumn 185, Issue 4, 2006, Pages 234-

Allergen injection immunotherapy

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GRASS POLLEN EXTRACT; HOUSE DUST ALLERGEN;

EID: 33748302891     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2006.tb00540.x     Document Type: Article
Times cited : (2)

References (8)
  • 1
    • 0030819663 scopus 로고    scopus 로고
    • Specific allergen immunotherapy for asthma. A position paper of the Thoracic Society of Australia and New Zealand and the Australasian Society of Clinical Immunology and Allergy
    • Specific allergen immunotherapy for asthma. A position paper of the Thoracic Society of Australia and New Zealand and the Australasian Society of Clinical Immunology and Allergy. Med J Aust 1997; 167: 540-544.
    • (1997) Med J Aust , vol.167 , pp. 540-544
  • 3
    • 0036170801 scopus 로고    scopus 로고
    • Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study)
    • Moller C, Dreborg S, Ferdousi HA, et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 2002; 109: 251-256.
    • (2002) J Allergy Clin Immunol , vol.109 , pp. 251-256
    • Moller, C.1    Dreborg, S.2    Ferdousi, H.A.3
  • 4
    • 0034847103 scopus 로고    scopus 로고
    • Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study
    • Pajno GB, Barberio G, De Luca F, et al. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy 2001; 31: 1392-1397.
    • (2001) Clin Exp Allergy , vol.31 , pp. 1392-1397
    • Pajno, G.B.1    Barberio, G.2    De Luca, F.3
  • 5
    • 0033960264 scopus 로고    scopus 로고
    • Economic evaluation of specific immunotherapy versus symptomatic treatment of allergic rhinitis in Germany
    • Schadlich PK, Brecht JG. Economic evaluation of specific immunotherapy versus symptomatic treatment of allergic rhinitis in Germany. Pharmacoeconomics 2000; 17: 37-52.
    • (2000) Pharmacoeconomics , vol.17 , pp. 37-52
    • Schadlich, P.K.1    Brecht, J.G.2
  • 6
    • 0034848357 scopus 로고    scopus 로고
    • Krankheitskosten-Studie und Kosten-Nutzen-Analyse der spezifischen Immuntherapie bei Asthma
    • Martens P, Lobermeyer K. Krankheitskosten-Studie und Kosten-Nutzen-Analyse der spezifischen Immuntherapie bei Asthma. Allergo J 2001; 10: 341-347.
    • (2001) Allergo J , vol.10 , pp. 341-347
    • Martens, P.1    Lobermeyer, K.2
  • 7
    • 0033549827 scopus 로고    scopus 로고
    • Long-term clinical efficacy of grass-pollen immunotherapy
    • Durham SR, Walker SM, Varga EM, et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999; 341: 468-475.
    • (1999) N Engl J Med , vol.341 , pp. 468-475
    • Durham, S.R.1    Walker, S.M.2    Varga, E.M.3
  • 8
    • 29544435005 scopus 로고    scopus 로고
    • Evaluation of near-fatal reactions to allergen immunotherapy injections
    • Amin HS, Liss GM, Bernstein DI. Evaluation of near-fatal reactions to allergen immunotherapy injections. J Allergy Chn Immunol 2006; 117: 169-175.
    • (2006) J Allergy Chn Immunol , vol.117 , pp. 169-175
    • Amin, H.S.1    Liss, G.M.2    Bernstein, D.I.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.